pylori eradication on the treatment of GERD was unknown This stu

pylori eradication on the treatment of GERD was unknown. This study was to explore the effect of H. pylori eradication on the therapy of reflux esophagitis. Methods: Patients with reflux symptoms

and diagnosed as reflux esophagitis were enrolled. Based on the results of rapid urease test and WS stain, the patients were divided into H. pylri positive and negative group. H. pylori positive patients were then randomly divided into: H. pylori eradication group and control group non-eradication group). Patient of H. pylori eradication group underwent H. pylori eradication therapy for ten days (EAC and sequential therapy) then Esomaprazole 20 mg bid for 46 days. Patients of H. pylori non-eradication group and H. pylori negative group underwent Esomeprazole 20 mg bid selleck monoclonal humanized antibody therapy for 56 day. Before and after therapy, the symptoms of reflux esophagitis MK-2206 purchase were compared. After 8 weeks of treatment, gastroscopy was performed again, and the healing rate was

compared. Results:  (1) 356 patients were enrolled. There were 178 H. pylori negative cases. For H. pylori positive group, 123 patients underwent H. pylori eradication (EAC group: 66 cases, sequential therapy group: 57 cases). (2) The healing rate of esophagitis in different H. pylori group was 81.8%, 78.9%, 78.2% in EAC, sequential therapy and non-eradicaiton group respectively (P = 0.869). The scores of reflux symptoms were 0.19, 0.11, 0.26 (P = 0.657). (3)The healing rate of esophagitis in H. pylori non-eradication group and H. pylori negative group was 78.2% and 82.6% 上海皓元医药股份有限公司 respectively (P = 0.462); The scores of reflux symptoms were 0.26 and 0.20 respectively (P = 0.653). Conclusion: H. pylori infection and eradication have not significant effect on the therapy of reflux esophagitis. Key Word(s): 1. H. pylori; 2. GERD; 3. RE; 4. eradication; Presenting Author: JOON HUR Additional Authors: JAE HYUCK CHANG, JONG HWAN LEE, HOON YOUNG KO, SOO JEONG KIM, MI AE SONG, TAE HO KIM, CHANG WHAN KIM, SOK WON HAN Corresponding Author: JAE HYUCK CHANG Affiliations:

Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital; Bucheon St. Mary’s Hospital Objective: Phlegmonous gastritis is the disease of acute suppurative inflammation in the stomach wall. It is a rare but rapidly progressive and potentially fatal disease. Its mortality rate remains very high because clinical diagnosis is delayed. Many patients with phlegmonous gastritis often undergo surgery. Methods: ———- Results: We present the case of 63-year-old woman with epigastric pain, fever, nausea and vomiting. The presumed diagnosis of acute phlegmonous gastritis was made by esophagogastroduodenoscopy (EGD) (A), abdominal computed tomography (CT) (B), endoscopic ultrasonography (EUS) (C), and deep submucosal biopsy assisted with hook knife (D).